SCHEMBL15323285

SCHEMBL15323285

FC(F)(F)C1CC[C](C2CCC(C(F)(F)F)CC2)CC1

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.30
NOS1 P29475 1/20 0.30
NOS2 P35228 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7848812 0.76
SCHEMBL18060 0.74
SCHEMBL1035408 0.74 NOS3 (0.36) NOS3NOS1NOS2
Ammonia Solution, Strong SCHEMBL3055814 0.71
SCHEMBL24229293 0.69 ESR2 (0.32) NOS3NOS1NOS2
SCHEMBL569231 0.69 TRIM24 (0.33) NOS3NOS1NOS2
SCHEMBL163531 0.67
SCHEMBL15323288 0.66 NOS3 (0.32) NOS3NOS1NOS2
SCHEMBL8134925 0.65
SCHEMBL12086405 0.64 ALDH1A1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013153535-A1 TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-10-17 WO claimed
WO-2013153535-A1 TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-10-17 WO disclosed